$568,496
＋28.6%
Vice President Clinical DEV THRU 9/30/22
2022
$536k org
31 hrs/wk
$34k other
--
Vice President Clinical DEV THRU 9/30/22 at Parker Institute for Cancer Immunotherapy
Fiscal year ended December 31, 2022. Published on January 25, 2026.
Total compensation
Justin Fairchild has been listed as an employee of Parker Institute for Cancer Immunotherapy in Form 990 filings since fiscal year 2021. Total compensation for Justin Fairchild has increased by 28.6% from 2021 to 2022.